These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21752182)

  • 41. Multidimensional Diagnostic Criteria for Chronic Pain: Introduction to the ACTTION-American Pain Society Pain Taxonomy (AAPT).
    Dworkin RH; Bruehl S; Fillingim RB; Loeser JD; Terman GW; Turk DC
    J Pain; 2016 Sep; 17(9 Suppl):T1-9. PubMed ID: 27586826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations.
    O'Connor AB; Turk DC; Dworkin RH; Katz NP; Colucci R; Haythornthwaite JA; Klein M; O'Brien C; Posner K; Rappaport BA; Reisfield G; Adams EH; Balster RL; Bigelow GE; Burke LB; Comer SD; Cone E; Cowan P; Denisco RA; Farrar JT; Foltin RW; Haddox DJ; Hertz S; Jay GW; Junor R; Kopecky EA; Leiderman DB; McDermott MP; Palmer PP; Raja SN; Rauschkolb C; Rowbotham MC; Sampaio C; Setnik B; Smith SM; Sokolowska M; Stauffer JW; Walsh SL; Zacny JP
    Pain; 2013 Nov; 154(11):2324-2334. PubMed ID: 24148704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ensuring transparency and minimization of methodologic bias in preclinical pain research: PPRECISE considerations.
    Andrews NA; Latrémolière A; Basbaum AI; Mogil JS; Porreca F; Rice ASC; Woolf CJ; Currie GL; Dworkin RH; Eisenach JC; Evans S; Gewandter JS; Gover TD; Handwerker H; Huang W; Iyengar S; Jensen MP; Kennedy JD; Lee N; Levine J; Lidster K; Machin I; McDermott MP; McMahon SB; Price TJ; Ross SE; Scherrer G; Seal RP; Sena ES; Silva E; Stone L; Svensson CI; Turk DC; Whiteside G
    Pain; 2016 Apr; 157(4):901-909. PubMed ID: 26683237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The ethics of pain clinical trials on persons lacking judgment ability: much to improve.
    Bellieni CV; Rocchi R; Buonocore G
    Pain Med; 2012 Mar; 13(3):427-33. PubMed ID: 22313615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conducting clinical trials to establish drug efficacy in chronic pain.
    Harden RN; Bruehl S
    Am J Phys Med Rehabil; 2001 Jul; 80(7):547-57. PubMed ID: 11421526
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks-American Pain Society-American Academy of Pain Medicine Pain Taxonomy Diagnostic Criteria for Acute Needle Pain.
    Zempsky WT; Campbell-Yeo M; Chambers CT; Cohen LL; Gagliese L; Kwok CHT; Trang T; Stevens B; Taddio A; Voepel-Lewis T; Schechter NL
    J Pain; 2023 Mar; 24(3):387-402. PubMed ID: 36243317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations.
    Dworkin RH; Turk DC; Peirce-Sandner S; Baron R; Bellamy N; Burke LB; Chappell A; Chartier K; Cleeland CS; Costello A; Cowan P; Dimitrova R; Ellenberg S; Farrar JT; French JA; Gilron I; Hertz S; Jadad AR; Jay GW; Kalliomäki J; Katz NP; Kerns RD; Manning DC; McDermott MP; McGrath PJ; Narayana A; Porter L; Quessy S; Rappaport BA; Rauschkolb C; Reeve BB; Rhodes T; Sampaio C; Simpson DM; Stauffer JW; Stucki G; Tobias J; White RE; Witter J
    Pain; 2010 May; 149(2):177-193. PubMed ID: 20207481
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The ACTTION-American Pain Society Pain Taxonomy (AAPT): an evidence-based and multidimensional approach to classifying chronic pain conditions.
    Fillingim RB; Bruehl S; Dworkin RH; Dworkin SF; Loeser JD; Turk DC; Widerstrom-Noga E; Arnold L; Bennett R; Edwards RR; Freeman R; Gewandter J; Hertz S; Hochberg M; Krane E; Mantyh PW; Markman J; Neogi T; Ohrbach R; Paice JA; Porreca F; Rappaport BA; Smith SM; Smith TJ; Sullivan MD; Verne GN; Wasan AD; Wesselmann U
    J Pain; 2014 Mar; 15(3):241-9. PubMed ID: 24581634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stimulating the development of mechanism-based, individualized pain therapies.
    Woodcock J; Witter J; Dionne RA
    Nat Rev Drug Discov; 2007 Sep; 6(9):703-10. PubMed ID: 17762885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional genomics of pain in analgesic drug development and therapy.
    Lötsch J; Doehring A; Mogil JS; Arndt T; Geisslinger G; Ultsch A
    Pharmacol Ther; 2013 Jul; 139(1):60-70. PubMed ID: 23567662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reporting of cross-over clinical trials of analgesic treatments for chronic pain: Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks systematic review and recommendations.
    Gewandter JS; McDermott MP; McKeown A; Hoang K; Iwan K; Kralovic S; Rothstein D; Gilron I; Katz NP; Raja SN; Senn S; Smith SM; Turk DC; Dworkin RH
    Pain; 2016 Nov; 157(11):2544-2551. PubMed ID: 27437786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Translational pain biomarkers in the early development of new neurotherapeutics for pain management.
    Arendt-Nielsen L; Nielsen TA; Gazerani P
    Expert Rev Neurother; 2014 Mar; 14(3):241-54. PubMed ID: 24490970
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Giving priority to preclinical pain measures resistant to existing drugs for developing innovative analgesics.
    Nagakura Y
    Drug Dev Res; 2018 Jun; 79(4):147-156. PubMed ID: 29732584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Animal models of pain for drug discovery.
    Joshi SK; Honore P
    Expert Opin Drug Discov; 2006 Sep; 1(4):323-34. PubMed ID: 23495903
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and Recommendations.
    Edwards RR; Schreiber KL; Dworkin RH; Turk DC; Baron R; Freeman R; Jensen TS; Latremoliere A; Markman JD; Rice ASC; Rowbotham M; Staud R; Tate S; Woolf CJ; Andrews NA; Carr DB; Colloca L; Cosma-Roman D; Cowan P; Diatchenko L; Farrar J; Gewandter JS; Gilron I; Kerns RD; Marchand S; Niebler G; Patel KV; Simon LS; Tockarshewsky T; Vanhove GF; Vardeh D; Walco GA; Wasan AD; Wesselmann U
    J Pain; 2023 Feb; 24(2):204-225. PubMed ID: 36198371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New molecules for the treatment of pain.
    Heinzmann S; McMahon SB
    Curr Opin Support Palliat Care; 2011 Jun; 5(2):111-5. PubMed ID: 21455071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Using pain quality assessment measures for selecting analgesic agents.
    Jensen MP
    Clin J Pain; 2006 Jan; 22(1 Suppl):S9-13. PubMed ID: 16344610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Why and for what are clinical trials the gold standard?
    Hansson SO
    Scand J Public Health; 2014 Mar; 42(13 Suppl):41-8. PubMed ID: 24553853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The need for fundamental reforms in the pain research field to develop innovative drugs.
    Nagakura Y
    Expert Opin Drug Discov; 2017 Jan; 12(1):39-46. PubMed ID: 27838932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An overview of pharmacology and acute pain: part one.
    Cox F
    Nurs Stand; 2010 Sep 29-Oct 5; 25(4):35-8. PubMed ID: 21033594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.